Current and Future Perspectives of Stem Cell Therapy in Dermatology.
- Author:
Christine M PRODINGER
1
;
Julia REICHELT
;
Johann W BAUER
;
Martin LAIMER
Author Information
- Publication Type:Review
- Keywords: Epidermal stem cells; Epidermolysis bullosa; Induced pluripotent stem cells; Mesenchymal multipotent stromal cells; Stem cell therapy; Wound healing
- MeSH: Adult; Blister; Dermatology*; Epidermolysis Bullosa; Humans; Induced Pluripotent Stem Cells; Regeneration; Skin; Stem Cells*; Wound Healing
- From:Annals of Dermatology 2017;29(6):667-687
- CountryRepublic of Korea
- Language:English
- Abstract: Stem cells are undifferentiated cells capable of generating, sustaining, and replacing terminally differentiated cells and tissues. They can be isolated from embryonic as well as almost all adult tissues including skin, but are also generated through genetic reprogramming of differentiated cells. Preclinical and clinical research has recently tremendously improved stem cell therapy, being a promising treatment option for various diseases in which current medical therapies fail to cure, prevent progression or relieve symptoms. With the main goal of regeneration or sustained genetic correction of damaged tissue, advanced tissue-engineering techniques are especially applicable for many dermatological diseases including wound healing, genodermatoses (like the severe blistering disorder epidermolysis bullosa) and chronic (auto-)inflammatory diseases. This review summarizes general aspects as well as current and future perspectives of stem cell therapy in dermatology.
